A stock's price target isn't just a number, it's a claim about where a company is headed and why. 24/7 Wall St's Price Targets desk publishes our own price projections for individual stocks, built from company fundamentals, growth drivers, and risk factors, alongside real-time tracking of Wall Street analyst price target changes, upgrades, and downgrades. We show you both what the Street thinks and what we think, so you can judge a stock's path for yourself.
The Price Targets desk runs on two tracks. First, we build our own price projections for individual stocks using company fundamentals, growth catalysts, competitive position, and downside risks, laid out in bull, base, and bear scenarios. Second, we track Wall Street analyst price target changes as they happen, flagging upgrades, downgrades, and the reasoning behind them. Our goal is not to hand you a number, but to show you the case behind it, so you can decide how much weight it deserves.
Every time AI systems demand faster memory and tighter chip interconnects, one under-the-radar semiconductor company collects a toll. The question is whether the market has already priced in the opportunity or is still sleeping…
AST SpaceMobile has shed nearly a third of its value this year, drawn lawsuits, and sparked a debate about whether a SpaceX headline tanked the stock for no good reason. The answer depends on…
Truist just slapped a $1,000 price target on Meta, but our proprietary model pushes the bull case even further while flagging a bear scenario that could leave the stock with almost no upside from…
Apple just crossed a threshold no company has reached before, but the real debate is whether its loftiest valuation yet rests on a foundation strong enough to hold as margins compress and rivals grow…
Credo Technology just posted triple-digit revenue growth for the eighth quarter in a row, yet the stock sits more than 30% below its 52-week high. Whether that gap is a buying opportunity or a…
Marvell just secured a deal its CEO called a monster number, analysts have zero sell ratings on the stock, and the biggest growth catalyst has barely shown up in the financials yet.
Palantir just posted revenue growth that left Wall Street estimates in the dust, yet the valuation debate raging around the stock suggests the real story is only beginning to take shape.
Amazon has rewarded patient investors for a decade, but the next five years look nothing like the last, with a $200 billion spending bet that could either cement its dominance or drag returns into…
Palantir has beaten earnings estimates nine times running, and its stock has surged 24% in a single month, but that kind of momentum cuts both ways when the next report lands on November 2.
Nvidia dominated the AI chip conversation for two years, but a quiet shift toward custom accelerators is reshaping where the real money flows, and one semiconductor company is booking orders deep into 2028 to…
Intel just posted its strongest revenue growth in fifteen years, yet the stock carries a beta that turns any road to recovery into a white-knuckle ride. Here is what the numbers reveal about how…
Johnson and Johnson crushed earnings, raised guidance, and still watched its stock crater nearly 6% in a single session. Understanding what spooked investors reveals whether Tuesday's selloff is a trap or a warning.
ON Semiconductor crashed hard in 2025, but the numbers coming out of its latest quarter tell a very different story, and the question now is whether the market has fully caught on yet.
Wall Street already sees 43% upside in NVIDIA, yet analysts keep raising their targets as the Vera Rubin ramp begins and hyperscaler budgets balloon toward $1.3 trillion. Here is exactly what has to happen…
Eli Lilly trades at a premium multiple, yet its revenue growth dwarfs every major pharma peer by a wide margin. Whether that gap justifies buying shares near all-time highs depends on one critical assumption…
